Stephen A Mihalcik
Overview
Explore the profile of Stephen A Mihalcik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mihalcik S, Chipman J, Sanda M, Regan M, Kaplan I, Wagner A, et al.
Pract Radiat Oncol
. 2018 Jun;
8(6):445-451.
PMID: 29935957
No abstract available.
2.
Mihalcik S, Chen M, Braccioforte M, Moran B, DAmico A
Eur Urol Focus
. 2017 Jul;
4(1):64-67.
PMID: 28753752
Patient Summary: The Prostate Intervention Versus Observation Trial (PIVOT) showed that radical prostatectomy did not benefit men with favorable-risk prostate cancer. Following the publication of PIVOT, the selection of men...
3.
Assessment of the Utility of Laparoscopy and Peritoneal Cytology in the Staging of Pancreatic Cancer
Mihalcik S, Virani S, Hong T, Niemierko A, Mino-Kenudson M, Kobayashi W, et al.
Pancreas
. 2017 Jul;
46(7):e60-e62.
PMID: 28697144
No abstract available.
4.
Mihalcik S, Rawal B, Braunstein L, Capuco A, Wong J, Punglia R, et al.
Ann Surg Oncol
. 2017 Feb;
24(7):1868-1873.
PMID: 28138856
Purpose: Risk factors for local recurrence (LR) following breast-conserving therapy (BCT) inform the need for local therapy. A Danish population-based cohort study identified residual disease on reexcision as an independent...
5.
Wu X, Tschumper R, Gutierrez Jr A, Mihalcik S, Nowakowski G, Jelinek D
PLoS One
. 2010 Dec;
5(12):e15549.
PMID: 21179576
Greater than 75% of all hematologic malignancies derive from germinal center (GC) or post-GC B cells, suggesting that the GC reaction predisposes B cells to tumorigenesis. Because GC B cells...
6.
Mihalcik S, Tschumper R, Jelinek D
Cell Cycle
. 2010 Nov;
9(24):4884-92.
PMID: 21099364
Together, circulating BAFF and dominant receptor BAFF-R homeostatically regulate the humoral immune system. Consistently aberrant BAFF-R expression in leukemic cells reveals an intimate connection of these cells' malignant physiology to...
7.
Mihalcik S, Huddleston 3rd P, Wu X, Jelinek D
J Immunol
. 2010 Jun;
185(2):1045-54.
PMID: 20554963
The B cell-activating factor of the TNF family receptor (BAFF-R), encoded by the TNFRSF13C gene, is critically important for transitional B cell survival to maturity. Thus, ligation of BAFF-R by...
8.
Chang S, Mihalcik S, Jelinek D
J Immunol
. 2008 May;
180(11):7394-403.
PMID: 18490739
B lymphocyte stimulator (BLyS) is a well-known direct costimulator of adaptive immune cells, particularly B lineage cells. However, we have reported recently that BLyS is also able to activate monocytes....